Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schnider

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
European Neurology|May 27, 1999
Posturographic findings in patients with idiopathic cervical dystonia before and after local injections with botulinum toxinC Wöber, P Schnider, N Steinhoff, et al.
Fortschritte Der Neurologie-Psychiatrie|July 1, 1996
[Hyperhomocyst(e)inemia--an independent risk factor of stroke]W Lalouschek, S Aull, L Deecke, et al.
Die Rehabilitation|August 1, 1996
[Subjective disability caused by physical and psychological complaints in long-term follow-up after transient ischemic attacks or "minor stroke"]P Schnider, E Auff, S Aull, et al.
The British Journal of Dermatology|April 1, 1997
Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palmsP Schnider, M Binder, E Auff, et al.
Der Nervenarzt|November 11, 1999
[Torticollis spasmodicus, blepharospasm and hemifacial spasm. Subjective evaluation of therapy by patients]P Birner, P Schnider, J Müller, et al.
Wiener Klinische Wochenschrift|October 28, 2004
[Botulinum toxin in the treatment of focal hyperhidrosis]P Schnider, E Moraru, H Kittler, et al.
Journal of Psychosomatic Research|July 25, 1998
Psychiatric comorbidity in patients with spasmodic torticollisT Wenzel, P Schnider, A Wimmer, et al.
Headache|January 1, 1995
MMPI and critical flicker frequency (CFF) analysis in headache patients with and without drug abuseP Schnider, J Maly, M Mraz, et al.
Chirality|May 29, 2000
Enantioselective hydrogenation of olefins with phosphinooxazoline-iridium catalystsD G Blackmond, A Lightfoot, A Pfaltz, et al.
Neurology|January 9, 2008
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type AG Kranz, T Sycha, B Voller, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
European Neurology|May 27, 1999
Posturographic findings in patients with idiopathic cervical dystonia before and after local injections with botulinum toxinC Wöber, P Schnider, N Steinhoff, et al.
Fortschritte Der Neurologie-Psychiatrie|July 1, 1996
[Hyperhomocyst(e)inemia--an independent risk factor of stroke]W Lalouschek, S Aull, L Deecke, et al.
Die Rehabilitation|August 1, 1996
[Subjective disability caused by physical and psychological complaints in long-term follow-up after transient ischemic attacks or "minor stroke"]P Schnider, E Auff, S Aull, et al.
The British Journal of Dermatology|April 1, 1997
Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palmsP Schnider, M Binder, E Auff, et al.
Der Nervenarzt|November 11, 1999
[Torticollis spasmodicus, blepharospasm and hemifacial spasm. Subjective evaluation of therapy by patients]P Birner, P Schnider, J Müller, et al.
Wiener Klinische Wochenschrift|October 28, 2004
[Botulinum toxin in the treatment of focal hyperhidrosis]P Schnider, E Moraru, H Kittler, et al.
Journal of Psychosomatic Research|July 25, 1998
Psychiatric comorbidity in patients with spasmodic torticollisT Wenzel, P Schnider, A Wimmer, et al.
Headache|January 1, 1995
MMPI and critical flicker frequency (CFF) analysis in headache patients with and without drug abuseP Schnider, J Maly, M Mraz, et al.
Chirality|May 29, 2000
Enantioselective hydrogenation of olefins with phosphinooxazoline-iridium catalystsD G Blackmond, A Lightfoot, A Pfaltz, et al.
Neurology|January 9, 2008
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type AG Kranz, T Sycha, B Voller, et al.
Pageof 7